HORIZON-HLTH-2024-DISEASE-03-14-two-stage
HORIZON-HLTH-2024-DISEASE-03-14-two-stage
Programme: Horizon Europe
4 projects · €28,698,445 total EU contribution (project-level) · 65 participating organizations · 22 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€28,698,445
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (7)
- Netherlands (7)
- Spain (6)
- CH (5)
- UK (5)
- BE (4)
- Germany (4)
- France (4)
- FI (3)
- PT (3)
- SE (3)
- AT (2)
- HR (2)
- TR (2)
- CY (1)
- CZ (1)
- DK (1)
- IE (1)
- LB (1)
- NO (1)
- PL (1)
- RO (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL2 projects · BE
- AARDEX GROUP SA1 projects · CH
- Leiden University Medical Center1 projects · NL
- ADX NEUROSCIENCES1 projects · BE
- CENTRE FOR INNOVATION IN MEDICINE1 projects · RO
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- AIDFM1 projects · PT
- BELGIAN VOLITION1 projects · BE
- DS1 projects · NO
- EGE UNIVERSITESI1 projects · TR
- Endometriose Stichting1 projects · NL
- ENDOMETRIOSIS UK1 projects · UK
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Synapsing Mental Disorders and Neurodegenerative diseases: Towards more effective diagnosis and management of psychiatric symptoms SYNAPSING · 101156566 | HORIZON | €6,999,922 | €0 | Details |
EUmetriosis: Transforming endometriosis care in Europe: an integrated approach to enhance understanding, diagnosis, tailored management and patient empowerment EUmetriosis · 101157146 | HORIZON | €6,981,844 | €0 | Details |
NEW STRATEGIES FOR THE EARLY DIAGNOSIS, RISK STRATIFICATION AND CO-MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLEMIA FH-EARLY · 101155885 | HORIZON | €7,286,252 | €0 | Details |
Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis MDR-RA · 101155807 | HORIZON | €7,430,427 | €0 | Details |